In Silico TRials guide optimal stratification of ATrIal FIbrillation patients to Catheter Ablation and pharmacological medicaTION: the i-STRATIFICATION study
Aims: Patients with persistent atrial fibrillation (AF) experience 50% recurrence despite pulmonary vein isolation (PVI), and no consensus is established for secondary treatments. The aim of our i-STRATIFICATION study is to provide evidence for stratifying patients with AF recurrence after PVI to op...
Main Authors: | Dasí, A, Nagel, C, Pope, MTB, Wijesurendra, RS, Betts, TR, Sachetto, R, Loewe, A, Bueno-Orovio, A, Rodriguez, B |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Oxford University Press
2024
|
Similar Items
-
What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
by: Dasí, A, et al.
Published: (2023) -
Catheter Management and Risk Stratification of Patients With in Inpatient Treatment Due to Acute Epididymitis
by: Mike Wenzel, et al.
Published: (2020-12-01) -
Social stratification /
by: 246808 Jackson, J. A.
Published: (1968) -
In-silico drug trials for precision medicine in atrial fibrillation: from ionic mechanisms to electrocardiogram-based predictions in structurally-healthy human atria
by: Dasí, A, et al.
Published: (2022) -
Social stratification/
by: 435153 Littlejohn, James
Published: (1972)